BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19091421)

  • 21. Synthesis and characterization of glucosyl-curcuminoids as Fe3+ suppliers in the treatment of iron deficiency.
    Ferrari E; Arezzini B; Ferrali M; Lazzari S; Pignedoli F; Spagnolo F; Saladini M
    Biometals; 2009 Oct; 22(5):701-10. PubMed ID: 19205899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives.
    Nurchi VM; Crisponi G; Lachowicz JI; Murgia S; Pivetta T; Remelli M; Rescigno A; Niclós-Gutíerrez J; González-Pérez JM; Domínguez-Martín A; Castiñeiras A; Szewczuk Z
    J Inorg Biochem; 2010 May; 104(5):560-9. PubMed ID: 20185179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
    Liu G; Men P; Harris PL; Rolston RK; Perry G; Smith MA
    Neurosci Lett; 2006 Oct; 406(3):189-93. PubMed ID: 16919875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,6-Dimethyl-4-hydroxy-3-pyridinecarboxylic acid and 4-hydroxy-2-methyl-3-pyridinecarboxylic acid as new possible chelating agents for iron and aluminium.
    Dean A; Ferlin MG; Brun P; Castagliuolo I; Yokel RA; Badocco D; Pastore P; Venzo A; Bombi GG; Di Marco VB
    Dalton Trans; 2009 Mar; (10):1815-24. PubMed ID: 19240917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.
    Yokel RA; Fredenburg AM; Meurer KA; Skinner TL
    Drug Metab Dispos; 1995 Oct; 23(10):1178-80. PubMed ID: 8654208
    [No Abstract]   [Full Text] [Related]  

  • 26. A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe
    Nurchi VM; de Guadalupe Jaraquemada-Pelaez M; Crisponi G; Lachowicz JI; Cappai R; Gano L; Santos MA; Melchior A; Tolazzi M; Peana M; Medici S; Zoroddu MA
    J Inorg Biochem; 2019 Apr; 193():152-165. PubMed ID: 30769225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake.
    Ma Y; Roy S; Kong X; Chen Y; Liu D; Hider RC
    J Med Chem; 2012 Mar; 55(5):2185-95. PubMed ID: 22339047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel tripodal tris-hydroxypyrimidinone sequestering agent for trivalent hard metal ions: synthesis, complexation and in vivo studies.
    Chaves S; Capelo A; Areias L; Marques SM; Gano L; Esteves MA; Santos MA
    Dalton Trans; 2013 May; 42(17):6033-45. PubMed ID: 23223558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
    Dobbin PS; Hider RC; Hall AD; Taylor PD; Sarpong P; Porter JB; Xiao G; van der Helm D
    J Med Chem; 1993 Aug; 36(17):2448-58. PubMed ID: 8355246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of physicochemical and in-vivo behavior of diastereomeric iron-59, gallium-68, and indium-111-EHPG trivalent metal complexes.
    Madsen SL; Bannochie CJ; Martell AE; Mathias CJ; Welch MJ
    J Nucl Med; 1990 Oct; 31(10):1662-8. PubMed ID: 2213190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new bis(3-hydroxy-4-pyridinone)-IDA derivative as a potential therapeutic chelating agent. Synthesis, metal-complexation and biological assays.
    Amélia Santos M; Gama S; Gano L; Cantinho G; Farkas E
    Dalton Trans; 2004 Nov; (21):3772-81. PubMed ID: 15510305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers.
    Zhou T; Kong XL; Liu ZD; Liu DY; Hider RC
    Biomacromolecules; 2008 May; 9(5):1372-80. PubMed ID: 18373358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and properties of novel iron(III)-specific fluorescent probes.
    Luo W; Ma YM; Quinn PJ; Hider RC; Liu ZD
    J Pharm Pharmacol; 2004 Apr; 56(4):529-36. PubMed ID: 15099448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkylaryl-amino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application.
    Chaves S; Gil M; Marques S; Gano L; Santos MA
    J Inorg Biochem; 2003 Sep; 97(1):161-72. PubMed ID: 14507473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
    Dehkordi LS; Liu ZD; Hider RC
    Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong metal ion size based selectivity of the highly preorganized ligand PDA (1,10-phenanthroline-2,9-dicarboxylic acid) with trivalent metal ions. A crystallographic, fluorometric, and thermodynamic study.
    Williams NJ; Dean NE; VanDerveer DG; Luckay RC; Hancock RD
    Inorg Chem; 2009 Aug; 48(16):7853-63. PubMed ID: 19603801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation.
    Nurchi VM; Cappai R; Chand K; Chaves S; Gano L; Crisponi G; Peana M; Zoroddu MA; Santos MA
    Dalton Trans; 2019 Nov; 48(43):16167-16183. PubMed ID: 31577287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and chemical characterization of the novel agronomically relevant pentadentate chelate 2-(2-((2-hydroxybenzyl)amino)ethylamino)-2-(2-hydroxyphenyl)acetic acid (DCHA).
    López-Rayo S; Hernández D; Lucena JJ; Escudero R; Gómez-Gallego M; Sierra MA
    J Agric Food Chem; 2010 Jul; 58(13):7908-14. PubMed ID: 20527987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, siderophore activity and iron(III) chelation chemistry of a novel mono-hydroxamate, bis-catecholate siderophore mimic: N(alpha),-N(epsilon)-Bis[2,3-dihydroxybenzoyl]-l-lysyl-(gamma-N-methyl-N-hydroxyamido)-L-glutamic acid.
    Mies KA; Gebhardt P; Möllmann U; Crumbliss AL
    J Inorg Biochem; 2008 Apr; 102(4):850-61. PubMed ID: 18272225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular structure and biological and pharmacological properties of 3-hydroxy-2-methyl-1-(beta-D-ribofuranosyl or pyranosyl)-4-pyridinone: potential iron overload drugs for oral administration.
    Liu G; Bruenger FW; Miller SC; Arif AM
    Bioorg Med Chem Lett; 1998 Nov; 8(21):3077-80. PubMed ID: 9873679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.